Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Asthma
|
1536 | 0.457 | 0.880 | 11 | 67585218 | missense variant | A/G | snv | 0.34 | 0.36 | 0.100 | 1.000 | 16 | 2004 | 2018 | ||||
Non-Small Cell Lung Carcinoma
|
712 | 0.457 | 0.880 | 11 | 67585218 | missense variant | A/G | snv | 0.34 | 0.36 | 0.090 | 1.000 | 9 | 2010 | 2017 | ||||
Carcinoma of bladder
|
309 | 0.457 | 0.880 | 11 | 67585218 | missense variant | A/G | snv | 0.34 | 0.36 | 0.080 | 1.000 | 8 | 2001 | 2019 | ||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.457 | 0.880 | 11 | 67585218 | missense variant | A/G | snv | 0.34 | 0.36 | 0.080 | 1.000 | 8 | 2002 | 2013 | ||||
Malignant neoplasm of urinary bladder
|
316 | 0.457 | 0.880 | 11 | 67585218 | missense variant | A/G | snv | 0.34 | 0.36 | 0.080 | 1.000 | 8 | 2001 | 2019 | ||||
Bladder Neoplasm
|
281 | 0.457 | 0.880 | 11 | 67585218 | missense variant | A/G | snv | 0.34 | 0.36 | 0.070 | 1.000 | 7 | 2001 | 2013 | ||||
Carcinoma, Ovarian Epithelial
|
327 | 0.457 | 0.880 | 11 | 67585218 | missense variant | A/G | snv | 0.34 | 0.36 | 0.060 | 1.000 | 6 | 2009 | 2018 | ||||
Chronic Obstructive Airway Disease
|
852 | 0.457 | 0.880 | 11 | 67585218 | missense variant | A/G | snv | 0.34 | 0.36 | 0.050 | 1.000 | 5 | 2004 | 2013 | ||||
melanoma
|
515 | 0.457 | 0.880 | 11 | 67585218 | missense variant | A/G | snv | 0.34 | 0.36 | 0.050 | 1.000 | 5 | 2009 | 2016 | ||||
Squamous cell carcinoma of the head and neck
|
348 | 0.457 | 0.880 | 11 | 67585218 | missense variant | A/G | snv | 0.34 | 0.36 | 0.050 | 1.000 | 5 | 2004 | 2019 | ||||
Acute lymphocytic leukemia
|
222 | 0.457 | 0.880 | 11 | 67585218 | missense variant | A/G | snv | 0.34 | 0.36 | 0.030 | 1.000 | 3 | 2008 | 2016 | ||||
Anemia
|
94 | 0.457 | 0.880 | 11 | 67585218 | missense variant | A/G | snv | 0.34 | 0.36 | 0.030 | 1.000 | 3 | 2009 | 2018 | ||||
Bronchial Hyperreactivity
|
18 | 0.457 | 0.880 | 11 | 67585218 | missense variant | A/G | snv | 0.34 | 0.36 | 0.030 | 1.000 | 3 | 2005 | 2013 | ||||
Carcinogenesis
|
355 | 0.457 | 0.880 | 11 | 67585218 | missense variant | A/G | snv | 0.34 | 0.36 | 0.030 | 1.000 | 3 | 2011 | 2014 | ||||
Childhood Acute Lymphoblastic Leukemia
|
261 | 0.457 | 0.880 | 11 | 67585218 | missense variant | A/G | snv | 0.34 | 0.36 | 0.030 | 1.000 | 3 | 2008 | 2018 | ||||
Epithelial ovarian cancer
|
129 | 0.457 | 0.880 | 11 | 67585218 | missense variant | A/G | snv | 0.34 | 0.36 | 0.030 | 1.000 | 3 | 2009 | 2016 | ||||
Glioblastoma
|
281 | 0.457 | 0.880 | 11 | 67585218 | missense variant | A/G | snv | 0.34 | 0.36 | 0.030 | 1.000 | 3 | 2010 | 2018 | ||||
Glioblastoma Multiforme
|
186 | 0.457 | 0.880 | 11 | 67585218 | missense variant | A/G | snv | 0.34 | 0.36 | 0.030 | 1.000 | 3 | 2010 | 2018 | ||||
Malignant neoplasm of ovary
|
315 | 0.457 | 0.880 | 11 | 67585218 | missense variant | A/G | snv | 0.34 | 0.36 | 0.030 | 1.000 | 3 | 2010 | 2018 | ||||
Myeloid Leukemia, Chronic
|
115 | 0.457 | 0.880 | 11 | 67585218 | missense variant | A/G | snv | 0.34 | 0.36 | 0.030 | 1.000 | 3 | 2010 | 2016 | ||||
ovarian neoplasm
|
757 | 0.457 | 0.880 | 11 | 67585218 | missense variant | A/G | snv | 0.34 | 0.36 | 0.030 | 1.000 | 3 | 2010 | 2018 | ||||
Thrombocytopenia
|
110 | 0.457 | 0.880 | 11 | 67585218 | missense variant | A/G | snv | 0.34 | 0.36 | 0.030 | 1.000 | 3 | 2018 | 2019 | ||||
Adenoma of large intestine
|
213 | 0.457 | 0.880 | 11 | 67585218 | missense variant | A/G | snv | 0.34 | 0.36 | 0.020 | 1.000 | 2 | 2005 | 2012 | ||||
Adult Acute Lymphocytic Leukemia
|
154 | 0.457 | 0.880 | 11 | 67585218 | missense variant | A/G | snv | 0.34 | 0.36 | 0.020 | 1.000 | 2 | 2008 | 2016 | ||||
Adult Glioblastoma
|
98 | 0.457 | 0.880 | 11 | 67585218 | missense variant | A/G | snv | 0.34 | 0.36 | 0.020 | 1.000 | 2 | 2010 | 2018 |